Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Intravenous Glibenclamide Reduces Lesional Water Uptake in Large Hemispheric Infarction.

Vorasayan P, Bevers MB, Beslow LA, Sze G, Molyneaux BJ, Hinson HE, Simard JM, von Kummer R, Sheth KN, Kimberly WT.

Stroke. 2019 Sep 20:STROKEAHA119026036. doi: 10.1161/STROKEAHA.119.026036. [Epub ahead of print]

PMID:
31537189
2.

Soluble ST2 links inflammation to outcome after subarachnoid hemorrhage.

Bevers MB, Wolcott Z, Bache S, Hansen C, Sastre C, Mylvaganam R, Koch MJ, Patel AB, Møller K, Kimberly WT.

Ann Neurol. 2019 Sep;86(3):384-394. doi: 10.1002/ana.25545. Epub 2019 Jul 30.

PMID:
31291030
3.

Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial.

Kimberly WT, Bevers MB, von Kummer R, Demchuk AM, Romero JM, Elm JJ, Hinson HE, Molyneaux BJ, Simard JM, Sheth KN.

Neurology. 2018 Dec 4;91(23):e2163-e2169. doi: 10.1212/WNL.0000000000006618. Epub 2018 Nov 16.

PMID:
30446594
4.

Combination of Clinical Exam, MRI and EEG to Predict Outcome Following Cardiac Arrest and Targeted Temperature Management.

Bevers MB, Scirica BM, Avery KR, Henderson GV, Lin AP, Lee JW.

Neurocrit Care. 2018 Dec;29(3):396-403. doi: 10.1007/s12028-018-0559-z.

PMID:
29949008
5.

Apparent Diffusion Coefficient Signal Intensity Ratio Predicts the Effect of Revascularization on Ischemic Cerebral Edema.

Bevers MB, Battey TWK, Ostwaldt AC, Jahan R, Saver JL, Kimberly WT, Kidwell CS.

Cerebrovasc Dis. 2018;45(3-4):93-100. doi: 10.1159/000487406. Epub 2018 Mar 13.

6.

Soluble ST2 predicts outcome and hemorrhagic transformation after acute stroke.

Wolcott Z, Batra A, Bevers MB, Sastre C, Khoury J, Sperling M, Meyer BC, Walsh KB, Adeoye O, Broderick JP, Kimberly WT.

Ann Clin Transl Neurol. 2017 Jul 5;4(8):553-563. doi: 10.1002/acn3.435. eCollection 2017 Aug.

7.

Reperfusion after ischemic stroke is associated with reduced brain edema.

Irvine HJ, Ostwaldt AC, Bevers MB, Dixon S, Battey TW, Campbell BC, Davis SM, Donnan GA, Sheth KN, Jahan R, Saver JL, Kidwell CS, Kimberly WT.

J Cereb Blood Flow Metab. 2018 Oct;38(10):1807-1817. doi: 10.1177/0271678X17720559. Epub 2017 Jul 21.

PMID:
28731381
8.

Critical Care Management of Acute Ischemic Stroke.

Bevers MB, Kimberly WT.

Curr Treat Options Cardiovasc Med. 2017 Jun;19(6):41. doi: 10.1007/s11936-017-0542-6. Review.

9.

Hyperglycemia is associated with more severe cytotoxic injury after stroke.

Bevers MB, Vaishnav NH, Pham L, Battey TW, Kimberly WT.

J Cereb Blood Flow Metab. 2017 Jul;37(7):2577-2583. doi: 10.1177/0271678X16671730. Epub 2016 Jan 1.

10.

Leptomeningeal transthyretin-type amyloidosis presenting as acute hydrocephalus and subarachnoid hemorrhage.

Bevers MB, McGuone D, Jerath NU, Musolino PL.

J Clin Neurosci. 2016 Jul;29:203-5. doi: 10.1016/j.jocn.2015.12.017. Epub 2016 Feb 16.

PMID:
26896372
11.

Eastchester clapping sign.

Mukerji SS, Bevers MB, Prasad S.

Neurol Clin Pract. 2014 Apr;4(2):178-179. doi: 10.1212/01.CPJ.0000435753.25245.47. No abstract available.

12.

RNAi targeting micro-calpain increases neuron survival and preserves hippocampal function after global brain ischemia.

Bevers MB, Ingleton LP, Che D, Cole JT, Li L, Da T, Kopil CM, Cohen AS, Neumar RW.

Exp Neurol. 2010 Jul;224(1):170-7. doi: 10.1016/j.expneurol.2010.03.007. Epub 2010 Mar 15.

13.

Knockdown of m-calpain increases survival of primary hippocampal neurons following NMDA excitotoxicity.

Bevers MB, Lawrence E, Maronski M, Starr N, Amesquita M, Neumar RW.

J Neurochem. 2009 Mar;108(5):1237-50. doi: 10.1111/j.1471-4159.2008.05860.x. Epub 2009 Jan 22.

14.

Neuroprotection with delayed calpain inhibition after transient forebrain ischemia.

Frederick JR, Chen Z, Bevers MB, Ingleton LP, Ma M, Neumar RW.

Crit Care Med. 2008 Nov;36(11 Suppl):S481-5.

15.

Mechanistic role of calpains in postischemic neurodegeneration.

Bevers MB, Neumar RW.

J Cereb Blood Flow Metab. 2008 Apr;28(4):655-73. Epub 2007 Dec 12. Review.

PMID:
18073773

Supplemental Content

Loading ...
Support Center